Biogen, Inc. (BIIB)
190.48
-0.20
(-0.10%)
USD |
NASDAQ |
May 07, 15:43
Biogen Price : 190.48 for May 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 327.90 |
| Gilead Sciences, Inc. | 133.90 |
| Johnson & Johnson | 222.14 |
| Eli Lilly & Co. | 973.77 |
| Apellis Pharmaceuticals, Inc. | 41.00 |
Price Related Metrics
| PE Ratio | 20.44 |
| PS Ratio | 2.921 |
| Price to Book Value | 1.508 |
| Price to Free Cash Flow | 12.11 |
| Earnings Yield | 4.89% |
| Market Cap | 28.12B |
| Operating PE Ratio | 12.24 |
| Normalized PE Ratio | 16.78 |